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Abstract 
Both inherited and sporadic mutations can give rise to a plethora of human diseases. Through myriad diverse cellular 
processes, sporadic mutations can arise through a failure to accurately replicate the genetic code or by inaccurate 
separation of duplicated chromosomes into daughter cells. The human genome has therefore evolved to encode a 
large number of proteins that work together with regulators of the cell cycle to ensure that it remains error-free. This 
is collectively known as the DNA damage response (DDR), and genome stability mechanisms involve a complex net-
work of signalling and processing factors that ensure redundancy and adaptability of these systems. The importance 
of genome stability mechanisms is best illustrated by the dramatic increased risk of cancer in individuals with underly-
ing disruption to genome maintenance mechanisms. Cilia are microtubule-based sensory organelles present on most 
vertebrate cells, where they facilitate transduction of external signals into the cell. When not embedded within the 
specialised ciliary membrane, components of the primary cilium’s basal body help form the microtubule organising 
centre that controls cellular trafficking and the mitotic segregation of chromosomes. Ciliopathies are a collection of 
diseases associated with functional disruption to cilia function through a variety of different mechanisms. Ciliopathy 
phenotypes can vary widely, and although some cellular overgrowth phenotypes are prevalent in a subset of cili-
opathies, an increased risk of cancer is not noted as a clinical feature. However, recent studies have identified surpris-
ing genetic and functional links between cilia-associated proteins and genome maintenance factors. The purpose 
of this mini-review is to therefore highlight some of these discoveries and discuss their implications with regards to 
functional crosstalk between the DDR and ciliogenesis pathways, and how this may impact on the development of 
human disease.
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Background
Recent work from several groups has strengthened the 
ever-expanding functional links between the DNA dam-
age response (DDR) and ciliogenesis. Given that both 
the DDR and primary ciliogenesis are stress response 
mechanisms that are inextricably linked to the cell cycle 
(see below), then these findings are perhaps not too 
unexpected in the context of their biological function. 
Furthermore, centrioles, which can help govern genome 
stability in proliferating cells through correct microtu-
bule organisation and accurate chromosome segregation, 
also form the basal body of primary cilia within quiescent 
cells. However, defects in DDR/genome stability fac-
tors are traditionally associated with inherited cancer-
predisposing diseases syndromes, whereas patients with 
ciliopathies do not have an increased risk of cancer devel-
opment. This makes recent findings that mutations in 
some DDR proteins are causal for a subset of human cili-
opathies all the more intriguing. The following sections 
will therefore give a brief overview of the recently discov-
ered genetic and functional links between DDR and cili-
ogenesis. We highlight key proteins identified to date that 
have dual roles in these biological processes.
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The DNA damage response and genome stability
DNA within cells is damaged on a daily basis from both 
exogenous sources e.g. UV radiation from the sun or car-
cinogens within tobacco smoke, and from endogenous 
sources e.g. metabolic by-products, errors introduced 
during DNA replication, or by chromosome segregation 
defects during mitosis [1]. In order to maintain genomic 
integrity and to minimise the accumulation of poten-
tially pro-mutagenic lesions within the genome, sophis-
ticated molecular mechanisms have evolved to resolve 
the numerous daily lesions that can occur within a cell, 
e.g. DNA breaks (single and double-stranded), base and 
sugar damage to the DNA backbone, DNA and DNA-
protein cross-links, base-pair mismatches incorporated 
during DNA replication and alkylation lesions on various 
sites of the DNA [1, 2]. These processes involve highly 
specialised sets of proteins and pathways that mediate 
the detection and repair of specific lesions, but often 
possess overlapping functions between the many differ-
ent DNA repair pathways [1, 2]. The detection and sub-
sequent repair of DNA damage are coordinated with 
the cell cycle through a series of complex regulatory and 
feedback mechanisms known collectively as cell cycle 
checkpoints [3–5]. Such checkpoints can be activated at 
various stages of the cell cycle process to allow time for 
DNA lesions to be resolved before progressing to the next 
stage of the cell cycle [5]. This is vital for maintaining the 
sequence integrity of the genome, as failure to carry out 
these process can lead to potential pro-mutagenic lesions 
being ‘fixed’ during replication and passed on to daughter 
cells during mitotic segregation of the chromosomes [4, 
6]. If the damage to the genome is beyond a cell’s abil-
ity to adequately repair it, then cell death mechanisms are 
triggered that act as a final fail-safe to prevent the propa-
gation and passage of potentially pro-mutagenic lesions 
to daughter cells [3–5]. The collective term for the detec-
tion and subsequent repair of potentially pro-mutagenic 
DNA lesions is the “DNA damage response” (DDR), 
which, together with pro-apoptotic mechanisms, acts as 
a critical barrier to the development of cancer [1, 7–9]. 
The importance of an intact DDR in combating tumouri-
genesis is perhaps best demonstrated by the numerous 
human cancer-predisposing disease syndromes that are 
a consequence of underlying mutations in DDR factors 
[1, 10, 11]. Additionally, it is well established that there 
is an increased risk of either breast or colorectal cancer 
in individuals with mutations in specific DDR factors 
e.g. BRCA1/2 and MSH2, MSH6 etc. [1, 10, 11]. Muta-
tions in genes encoding a plethora of DDR factors can 
also lead to a range of other human inherited or spo-
radic disorders with several overlapping clinical pheno-
types [1, 10]. The most common overlapping clinical trait 
associated with mutations in such factors is congenital 
microcephaly, potentially due to defects in neurogenesis 
during the developing embryo [12]. The rapid cell expan-
sion that takes place during this process is susceptible 
to DNA damage [13], and also requires accurate asym-
metric cell division. As such, mutations in proteins that 
have important functions in DNA replication, DNA 
repair, centrosome maintenance, microtubule regulation, 
and mitosis have all been shown to be causal for several 
human microcephalic disorders [12] (see Table  1 for 
some examples).
DDR factors and centrosomes
The centrosome acts as the major site of microtubule 
nucleation and organisation in both interphasic and 
mitotic cells, and forms the basis of the basal body dur-
ing ciliogenesis (see below). It consists of two orthogo-
nally positioned, cylindrically shaped structures known 
as centrioles, which are surrounded by an electron-
dense matrix termed the pericentriolar material (PCM) 
and acts as an organised scaffold that facilitates protein 
recruitment to the centrosome. Associated with the PCM 
are numerous particles termed centriolar satellites, which 
contain many components of the PCM and other centro-
somal proteins [14–17]. The formation, maturation and 
duplication of centrosomes are regulated in unison with 
the cell cycle [16]. As such, defects in cell cycle progres-
sion, e.g. following the induction of DNA damage, can 
lead to changes in the composition and architecture of 
centriolar satellites and give rise to centrosome duplica-
tion errors [18–21]. As the duplication of centrosomes 
occurs during the G1/S-phases of the cell cycle, cells 
experiencing persistent DNA damage and checkpoint 
activation and/or replication stress which prolongs the 
time spent within S-phase, can give rise to abnormal cen-
trosome duplication called supernumerary centrosomes 
[21–23]. Additionally, it was recently shown that some 
centriolar satellites form an interactome together with 
centrosomal proteins to promote CDK2 activity and effi-
cient centriolar duplication [24].
Given the important roles of the centrosome within 
the cell and functional overlap with DDR (see above), it 
is perhaps not too surprising that defects in centrosome-
associated factors that function in DDR processes give 
rise to a range of human inherited disorders [11, 25, 26] 
that include several microcephalic disorders and ciliopa-
thies (Table  1). This includes examples of clinicopatho-
logical overlap between ciliopathy and microcephaly 
patients [27], as well as mutations in the microtubule-
regulating protein CENPF that are associated with both 
ciliopathy and microcephaly disorders [28]. In addition, 
there is a long-standing connection between supernu-
merary centrosomes, genome instability and cancer 
development and/or progression, since supernumerary 
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centrosomes are a common hallmark of cancer cells [25, 
29–34]. A functional consequence of abnormal centro-
some number within the context of cancer was recently 
highlighted by the demonstration that centrosome ampli-
fication can lead to cell adhesion changes that can help 
drive the invasive phenotypes associated with metastatic 
cancer cells [35]. However, it is interesting to note that 
even given the dual role of many centrosome-associated 
proteins within ciliogenesis (Table 1), and that cilia-asso-
ciated signalling pathways are often dysregulated in can-
cers, there is not an overt association between ciliopathy 
and cancer risk (discussed below).
Functional links between the DDR and centrosomes 
have been previously inferred by the centrosomal locali-
sation of several DDR factors including the DNA repair 
proteins BRCA1, BRCA2, PARP1 and NBS1; the DDR 
signalling kinases ATM, CHK1 and CHK2; and the cell 
cycle checkpoint and transcriptional regulator TP53 
[36, 37]. However, it must be noted that antibody cross-
reactivity in these studies cannot be excluded without 
thorough reagent validation [38, 39]. More convincing 
mechanistic insights into biological function come from 
the observation that the E3 ubiquitin ligase BRCA1 ubiq-
uitylates gamma-tubulin at centrosomes, which is impor-
tant for restricting centrosome over-duplication during S 
and G2 phases of the cell cycle [40] that, in turn, is regu-
lated by NBS1 and the upstream DDR-associated kinase 
ATR [41]. The DDR effector kinase CHK1 was initially 
reported to also localise to the centrosome [36, 42], but 
this was subsequently determined to be through a non-
specific interaction of the CHK1 antibody cross-reacting 
with the centrosomal protein CCDC151 [39]. It is there-
fore not currently clear how CHK1 may contribute to 
the mechanism of centrosome amplification by NBS1 
and BRCA1 functions which are both capable of activat-
ing CHK1 in response to DNA damage and/or replica-
tion stress [43, 44]. However, CHK1 function has since 
been shown to be important for regulating expansion of 
the PCM [45], a process that has been shown to affect 
the growth of daughter centrioles [46]. Additionally, 
CHK1 together with the centrosomal protein MCPH1 
(Table 1) can control mitotic entry [39, 47]. Interestingly, 
changes in MCPH1 expression have been associated with 
both breast and ovarian cancer grade, which may be a 
consequence of increased cell division in higher-grade 
tumours [48, 49]. Changes in either centriole duplication 
in S-phase due to PCM expansion or inappropriate cell 
cycle timing could therefore be mechanisms by which 
alterations in CHK1 function could impact centrosome 
integrity, although further studies to address these issues 
are clearly needed.
Interactions between centrosome-associated and DDR 
proteins can also occur in response to exogenous stress. 
For example, the centrosomal and ciliogenesis-pro-
moting protein CEP164 (Table  1) is phosphorylated by 
the DDR-associated kinases ATM and ATR in response 
to several genotoxic stresses where it helps establish a 
G2/M damage checkpoint and regulate cell division pro-
cesses [50]. CEP164 has also been shown to re-localise 
to sites of UV-induced damage, and is required for effi-
cient cellular responses to UV-induced DNA damage 
[51]. However, it is presently not clear if this is a specific 
response to UV, or a more general response to replica-
tion-blocking lesions and/or induction of p38-mediated 
stress signalling pathways. It is interesting to note that 
the core centriolar factor centrin 2 has both centriolar 
localisation and a major nuclear component. The latter 
functionally responds to UV-induced DNA damage and 
physically interacts with XPC to promote efficient repair 
of UV-induced DNA lesions [52–54]. Recent studies sug-
gest that ATM can also act as a versatile protein kinase 
during cytoplasmic signalling processes [55], and ATM 
may therefore have a “non-canonical DDR” ciliary role 
that maintains genome stability and mediates cellular 
responses to various other cellular stresses. Indeed, there 
are a number of centrosome-associated proteins that 
are known or predicted in  vivo substrates of the DDR-
associated kinases ATM, ATR and DNA-PKcs, which 
include centrosomal and ciliary proteins such as ninein, 
PCM1 and INPP5E [56]. Another example of a centro-
some protein that is a direct substrate of DDR kinases is 
CEP63 (Table  1), which is phosphorylated by ATM and 
ATR to promote mitotic spindle assembly [57], and has 
been shown to regulate centriole duplication [58, 59], 
potentially through centrosomal CDK activity [60]. How-
ever, unlike CEP164, a direct role for CEP63 in cellular 
response to DNA damage is yet to be elucidated. Addi-
tionally, although not a directly associated DDR kinase, 
the kinase Aurora A regulates mitotic entry and exit as 
well as cilium disassembly [61]. One of Aurora A’s sub-
strates is the mitotic kinase PLK1 which can also pro-
mote cilia disassembly and has been shown to function 
in cell cycle checkpoint recovery following DNA damage 
[62, 63]. Consistent with these findings is work from sev-
eral groups linking the APC, which co-ordinates mitotic 
progression in response to DNA damage and replication 
stress, to ciliogenesis [64, 65]. Finally, we have recently 
demonstrated that some centriolar satellite proteins have 
dual roles in promoting ciliogenesis and preventing the 
accumulation of DNA damage within the cell [20, 66].
The examples highlighted here (see Table  1 for addi-
tional examples) demonstrate both physical and func-
tional interactions between DDR centrosomal proteins, 
many of which control ciliogenesis. The majority of inter-
play between the DDR and centrosome proteins involves 
either regulating centrosome duplication through the 
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cell cycle, or regulating accurate timing of mitotic entry 
through the spindle pole body. Such crosstalk between 
these processes may therefore be important for driving 
faithful cell division during early development, as shown 
by the example of microcephalic disorders, and may also 
be linked to uncontrolled cell division during tumour 
progression and/or development. Further elucidation of 
the functional connectivity between these cellular pro-
cesses should provide new insights into a number of 
human inherited and sporadic disorders (Table 1).
The cellular role of mammalian cilia
Primary cilia are microtubule-based organelles that 
sense and transduce extracellular signals on many cell 
types during the G1/G0 phase of the cell cycle [67, 68]. 
Cilia have a complex ultrastructure with compartmen-
talisation of molecular components that combine in 
functional modules. The loss or mutation of these com-
ponents can disrupt ciliary functions such as the control 
of protein entry and exit from the cilium, regulation of 
signalling cascades and control of the cell cycle. In par-
ticular, the ciliary transition zone has been suggested 
as a hub that mediates and integrates paracrine signal-
ling during embryonic development and tissue morpho-
genesis, including the SHH, WNT and Notch signalling 
pathways [69–72]. A common mechanism for regulating 
these pathways appears to be the discrete compartmen-
talisation of signalling components to the cilium. As a 
paradigm for other pathways, Smo, the co-receptor and 
transducer for SHH, translocates into and then activates 
GLI transcription factors within the cilium [73]. Canoni-
cal WNT/β-catenin signalling is also constrained by 
compartmentalisation of the WNT signalling component 
Jouberin, ensuring the translocation of β-catenin away 
from the nucleus and into the cilium [74]. In turn, Notch 
signalling is proposed to be a modulator of ciliary SHH 
signalling by regulating the ciliary translocation of Smo 
[75]. More recently, the mTOR [76, 77], Hippo [78–80], 
TGFβ [81] and PDGF [82] signalling pathways have all 
been shown to be regulated through ciliary-dependent 
mechanisms, with diverse consequences on cell prolifera-
tion and size, differentiation, autophagy, apoptosis and 
tumourigenesis. It is presently unclear to what extent any 
of the ciliary-related signalling pathways modulate DDR, 
although a recent study has suggested that the Notch1 
receptor binds to and negatively regulates the activity of 
the DDR-associated kinase ATM [83], and may be part of 
an interactome with other DDR-associated factors [84]. 
It will therefore be interesting to determine what effect 
any further connections between the Notch1 receptor 
and ATM have on ciliogenesis. From these studies, the 
reported connections between centrosomal and ciliary 
proteins with DDR link the processes of cilium biogen-
esis and disassembly with the mitotic and S-phase check-
point pathways that monitor failures in DNA replication 
and chromosome transmission. The disruption of these 
ciliary processes may therefore permit dysregulated cell 
proliferation, a hallmark of all cancers. Conversely, recent 
work has led to the growing recognition that alterations 
of replication timing and progression, leading to replica-
tion stress and activation of DDR, are features of some 
renal ciliopathies [85, 86].
Systems biology approaches have revealed a wide-
spread role for spliceosome proteins and other mRNA-
processing factors in preventing DNA damage, which in 
some cases was caused by aberrant RNA–DNA struc-
tures [87]. Many of the same spliceosome and mRNA-
processing components, including those mutated in 
inherited forms of the retinal degeneration condition ret-
initis pigmentosa, were also identified in a recent reverse 
genetics screen for genes and pathways regulating cilio-
genesis [88]. Loss of primary cilia has also been observed 
in tumours of many cancers, including breast cancer [89] 
and renal cell carcinomas [90], prompting suggestions 
that the cilium may be a “tumour suppressor organelle”. 
For example, familial adenomatous polyposis (FAP or 
Gardner syndrome), an inherited Wnt-dependent can-
cer, may be mediated by a ciliary-dependent mechanism 
[91]. However, the mechanistic details to explain these 
observations remain unknown, so it is unclear if cilia loss 
contributes to or is merely a consequence of the nuclear 
events of replication stress and activated DDR.
It is also important to appreciate that signalling path-
ways have multiple roles in maintaining normal adult 
tissue homeostasis that are distinct to developmental sig-
nalling during embryogenesis. The role of primary cilia 
in developmental SHH signalling is well established, but 
this pathway also regulates the survival and proliferation 
of tissue progenitor and stem cell populations [92]. These 
mitogenic roles can explain why abnormal activation of 
the canonical SHH signalling pathway, either through 
activating mutations in pathway components or by ligand 
production in an autocrine mechanism, predisposes to 
cancer in many different tissues, including medulloblas-
toma, glioblastoma and basal cell carcinoma [93–95]. 
Whether primary cilia are essential for the mitogenic 
roles of SHH is presently unclear. For example, tumour-
igenesis caused by activating mutations in the SHH co-
receptor Smo is decreased if cilia are ablated, whereas 
cilia loss increased tumourigenesis caused by activated 
GLI2, a transcriptional effector of SHH signalling [96]. 
However, the complex mitogenic roles of SHH provide 
one explanation of why there is no apparent increase in 
cancer incidence in ciliopathy patients.
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Emerging genetic and functional links between the DDR 
and primary cilia
It has recently been shown that in proliferating cells, sev-
eral centriolar satellite proteins are re-structured follow-
ing exogenous stresses such as UV that, in turn, repress 
inhibitory signals and facilitate ciliogenesis [97]. Simi-
larly, stress-induced autophagy can affect the composi-
tion of centriolar satellites to promote ciliogenesis [98]. 
Conversely, stress signalling through the primary cilium 
helps regulate autophagy by promoting the formation 
of the autophagosome [99]. We have also demonstrated 
that some centriolar satellite proteins act to promote cili-
ogenesis as well as genome stability [20, 66], which may 
in part be through regulation of the composition of the 
centrosome and centriole duplication through CDK2 
activity [24]. Stress signals emanating from DNA damage 
can be either intra- or intercellular through a variety of 
mechanisms involving cell–cell contacts and/or extracel-
lular signalling collectively known as ‘bystander effects’ 
[100]. Interplay between the DDR and primary cilia may 
therefore involve both internal functional interactions 
between DDR and centriolar/basal body proteins, as 
well as external signals from neighbouring cells. The last 
few years have seen emerging functional links between 
autophagy and DDR, where autophagy facilitates cell fate 
following DNA damage and also helps prevent genome 
instability to combat tumourigenesis [101, 102]. Inter-
estingly, autophagy processes may also be responsive to 
DNA damage-induced bystander effects, facilitating both 
intra- and intercellular stress signalling. This complex 
interplay between these cellular stress-responsive mech-
anisms has potential implications for ciliopathies and 
microcephalic disorders, as well as for cancer [24, 101].
In addition to the examples given above that demon-
strate physical and functional connections between DDR 
and centrosomal proteins, work from several groups has 
revealed direct genetic and functional links between 
DDR and ciliogenesis (Tables 1, 2). As mentioned above, 
the pro-ciliogenesis centrosomal protein CEP164 is reg-
ulated by DDR kinases and promotes cellular responses 
to UV-induced DNA damage [50, 51]. More recently, 
homozygous recessive mutations in CEP164 were shown 
to be causal for a subset of nephronophthisis-related cili-
opathies, with mutant zebrafish models exhibiting both 
ciliopathy phenotypes and inefficient responses to DNA 
damage [103]. Furthermore, this study also showed that 
NPHP10 (also known as SDCCAG8), which usually 
resides at centrosomes, re-localised to nuclear foci in 
response to DNA damage [103], and a subsequent study 
has suggested that deficiency in NPHP10 (either in cell 
models or in cells derived from knock-out mice) leads 
to elevated levels of DNA damage and cell cycle check-
point activation [104]. Consistent with an established 
functional role for some of the NEK kinase family mem-
bers in both DDR and ciliogenesis [105], it was recently 
reported that the ciliopathy-associated kinase NEK8 
(Table 1) is important in controlling cellular responses to 
replication stress through the DDR kinase ATR and limit-
ing CDK activity to suppress DNA break formation [106]. 
What is more surprising, given the non-overlapping 
clinical phenotypes of NEK8-associated ciliopathies and 
ATR-associated Seckel syndrome patients, is that cells 
expressing a ciliopathy-associated kinase mutant NEK8 
had an increase in DNA damage and cell cycle defects, 
and that the kidneys of NEK8 mutant mice accumulated 
DNA damage [106]. Furthermore, the centrosomal pro-
tein CEP290, mutated in a range of ciliopathies including 
Joubert syndrome, has also been implicated in the regula-
tion of DNA replication stress and DDR (Table  1), sug-
gesting that chronic replication stress may be a key driver 
in the development of some ciliopathies [85, 86]. Similar 
to the NEK8 study, cells expressing mutant CEP290 also 
had inappropriate CDK activity. Tissue-specific replica-
tion stress in certain genetic backgrounds may therefore 
be a common mechanism that drives the development of 
a subset of ciliopathies, and suggests that CDK may be a 
potential therapeutic target for such diseases [85, 86].
It is intriguing that the same study identifying CEP164 
mutations as causative for a subset of nephronophthisis-
related ciliopathies also identified causative mutations 
in MRE11 (Table 2). MRE11 interacts stoichiometrically 
with RAD50 and NBS1 (forming the so-called MRN 
complex) to facilitate key functions of DNA repair pro-
cesses [103]. Specifically, germ-line mutations in either 
NBS1 or MRE11 give rise to the cancer-predisposing 
inherited disorders Nijmegen breakage syndrome and 
ataxia-telangiectasia-like disorder (ALTD), respectively 
[107, 108]. Furthermore, MRE11 has been shown to func-
tion as a barrier to tumourigenesis [109, 110], and inher-
ited heterozygous mutations in MRE11, NBS1 or RAD50 
are associated with a low-intermediate penetrance risk 
of breast cancer [111–113]. It is presently unclear how 
or why specific mutations in MRE11 in particular can 
give rise to ciliopathies. This raises interesting questions 
about whether mutations in other members of the key 
DDR-associated MRN complex (MRE11-RAD50-NBS1), 
mutations which cause inherited cancer syndromes [114], 
may also be causative for other renal-retinal ciliopathies. 
Perhaps even more surprising was the recent discov-
ery that mutations in the Fanconi Anaemia and cancer-
associated nuclease FAN1 (Table 2; [115–119]) could be 
causative for a subset of karyomegalic interstitial nephri-
tis-type ciliopathies [120]. As this enzyme is involved 
in the repair of DNA lesions that block DNA replica-
tion, the study suggested that defective nuclease activ-
ity within certain organs could drive cellular senescence 
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following increased exposure to genotoxins (perhaps 
arising from a heightened active metabolism). This may 
be a similar scenario to the proposed heightened replica-
tion stress observed in the kidneys of both CEP290 and 
NEK8-deficient mice (see above). Although this may be 
a mechanism by which FAN1 mutations can give rise to 
ciliopathies, the underlying biology may be more compli-
cated, especially given that phenotypes associated with 
karyomegalic interstitial nephritis-type ciliopathies are 
not evident in patients with Fanconi anaemia (FA). Such 
phenotypic discrepancy may also be, in part, due to the 
redundancy within the pathways that function to resolve 
DNA replication-impeding lesions [121].
In addition to these genetic studies, several groups 
have also uncovered functional links to ciliogenesis 
for proteins traditionally associated with the DDR. An 
example of this is the recent finding that ATR localises 
to the basal body in mouse photoreceptor cells (Table 2), 
and is important for ciliogenesis during the developing 
eye [122]. ATR is also required for ciliary-related Sonic 
hedgehog signalling in  vitro and in  vivo, but appears to 
be largely dispensable for ciliogenesis, in a role that is 
distinct from its function in DDR and replication [123]. 
Another finding is that mutations in DNA replication 
licensing factors such as ORC1 (Table 2), were causative 
for the microcephalic disorder Meier–Gorlin syndrome 
(MGS) and were also shown to affect ciliogenesis through 
impaired SHH signalling [124]. The AAA-ATPase protein 
VCP/p97, which regulates the localisation of several DDR 
factors at DNA damage sites [125], has been shown to be 
required for ciliogenesis (Table 2), when it may carry out 
similar functions in regulating E3 ligase-mediated ubiq-
uitylation of proteins at the basal body [126]. Finally, the 
protein ATMIN, a binding partner of the key DDR kinase 
ATM and also important for cellular responses to replica-
tion stress [127, 128], has also been shown to be impor-
tant for ciliogenesis during morphogenesis of both the 
lungs and kidneys in developing mice through its abil-
ity as a transcription factor to regulate WNT signalling 
[129, 130]. Collectively, these studies demonstrate both 
genetic and functional links between DDR and ciliogen-
esis (Table 2).
The human primary cilium and cancer
Contrary to these recent discoveries involving DDR-asso-
ciated factors in human ciliopathies is the general obser-
vation that an increased risk or incidence of cancer is not 
generally associated with human ciliopathies. Exceptions 
include Birt–Hogg–Dubé syndrome and Von Hippel–
Lindau syndrome that are both inherited renal cancer 
disorders with some clinical features of ciliopathies [131, 
132]. Furthermore, although patients with polycystic kid-
ney disease have benign renal cysts as a consequence of a 
cell overgrowth phenotype, they do not have an increased 
risk of developing cancer, and may in fact have an overall 
reduced cancer risk compared with non-affected individ-
uals [133, 134]. It is not clear why this may be the case, 
but it has been suggested that a coincident increased rate 
of cell death through either apoptotic and/or autophagy 
mechanisms might help reduce cancer risk in affected 
individuals. A similar phenomenon has been reported 
for genetic reduction of ATR activity limiting the tumour 
growth of P53-deficient tumours in mice [135], although 
an increased risk of cancer in some Seckel syndrome 
patients has been reported, with at least one of these 
having a causative genetic defect in the ATR gene [136, 
137]. Interestingly, it has recently been suggested that 
increased replication stress, similar to that often seen in 
cancers due to oncogene activation, is a phenotype asso-
ciated with a subset of ciliopathies, such as CEP290-asso-
ciated Joubert syndrome [85, 86]. Thus, it may be that a 
certain level of tolerance to heightened replication stress 
is needed in order to drive more tumourigenic pheno-
types associated with DDR-related diseases, which is 
not selected during the development of the majority of 
human ciliopathies.
The studies briefly highlighted here provide compel-
ling evidence of ever-expanding genetic and functional 
links between DDR and ciliogenesis pathways. However, 
the discrepancies between the phenotypes of DDR-asso-
ciated cancer-predisposing syndromes and ciliopathies 
(Tables  1, 2) do not fit with our current limited knowl-
edge of how these two pathways could be connected. 
This may reflect the functional impact each pathway has 
within both developing and differentiated tissue, as well 
as how normal or aberrant pathway function may affect 
both pre-cancerous lesions and transformed cells.
Concluding remarks
The purpose of this mini-review is to highlight emerg-
ing links between cellular responses to DNA damage 
and ciliogenesis. Although some of these studies provide 
more mechanistic insight into this functional overlap 
than others, we are still some way from fully understand-
ing the intricate interplay between DDR and ciliogenesis 
factors. Such links were initially striking given the estab-
lished role the DDR plays in preventing tumourigenesis 
and the lack of any increased cancer risk in the major-
ity of human ciliopathy patients. However, it is becoming 
clear from recent genetic and functional-based studies 
that a subset of DDR and ciliogenesis factors have dual 
roles in maintaining genomic integrity and primary cilia 
biology. The majority of this duality appears to stem from 
the necessity of a cell to regulate centrosome duplication 
and mitotic spindle integrity, with several DDR proteins 
localising to the centrosome and/or regulating cell cycle 
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progression and, in turn, centriole duplication events. 
Additionally, several centriolar satellites help maintain 
appropriate centrosome structures and microtubule 
integrity to limit the accumulation of post-mitotic DNA 
damage. Finally, aberrant mitogenic signals (potentially 
through a common mechanism of inappropriate CDK 
activity) can give rise to replication stress which can, in 
turn, lead to aberrant centrosome duplication and matu-
ration processes. As such, heightened replication stress 
may be a common source of disrupted centrosome func-
tion in cancer, and aberrant cilia function in ciliopathies.
The majority of human cells are ciliated with the cil-
ium acting as a signalling hub for several interconnected 
stress response pathways, which are in constant com-
munication with the DNA damage response pathways 
and cell cycle regulators. Recent discoveries demon-
strating that autophagy and ciliogenesis can co-regulate 
each other, and that autophagy is responsive to oxida-
tive stress/DNA damage and can regulate DNA repair 
processes, further draw links between primary cilia and 
the DDR. Such functional interplay has implications for 
human disease, which is highlighted by the recent discov-
eries of mutations in proteins, traditionally thought to be 
solely involved in DNA repair processes, being causative 
for a subset of human ciliopathies with degenerative dis-
eases of the kidney and retina. With the advent of next-
generation sequencing of larger clinical cohorts, it will 
also be interesting to see if additional DDR factors and 
autophagy factors are implicated in ciliopathies, and if 
dysregulation in any cilia-associated factors is associated 
with an increased risk of cancer development and pro-
gression. Indeed, given the young age and small cohort 
of current ciliopathy patients with causative mutations 
in either FAN1 or MRE11, it is too early to determine if 
these patients have an increased risk of developing can-
cer. Given that mutations in both these proteins can give 
rise to various cancers (see above), one may predict that 
these ciliopathy patients may have a heightened risk of 
developing cancer compared with the general population 
and some other ciliopathy cohorts. For these conditions, 
pathogenic mechanisms of replication stress leading to 
DNA damage, concomitant with or upstream of primary 
cilia function, are an area of exciting future research. 
Finally, since ciliogenesis and replication stress are poten-
tially reversible with small molecule approaches, these 
findings also reveal new therapeutic intervention oppor-
tunities as possible treatment regimes for these diseases.
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